Linda Ho

3.6k total citations
47 papers, 2.8k citations indexed

About

Linda Ho is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Linda Ho has authored 47 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 13 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Linda Ho's work include Cervical Cancer and HPV Research (30 papers), Genital Health and Disease (10 papers) and Molecular Biology Techniques and Applications (8 papers). Linda Ho is often cited by papers focused on Cervical Cancer and HPV Research (30 papers), Genital Health and Disease (10 papers) and Molecular Biology Techniques and Applications (8 papers). Linda Ho collaborates with scholars based in United Kingdom, United States and Spain. Linda Ho's co-authors include George Terry, Jack Cuzick, Albert Singer, P. Londesborough, Anne Szarewski, Cosette M. Wheeler, M Anderson, Tony Hollingworth, Louise Cadman and Janet Austin and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Linda Ho

44 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Ho United Kingdom 25 2.5k 1.0k 651 538 435 47 2.8k
CJLM Meijer Netherlands 15 1.8k 0.7× 876 0.9× 352 0.5× 488 0.9× 325 0.7× 16 2.3k
Ruediger Ridder Germany 26 2.6k 1.0× 1.4k 1.3× 866 1.3× 870 1.6× 238 0.5× 36 3.4k
Jesper Bonde Denmark 30 2.0k 0.8× 699 0.7× 732 1.1× 617 1.1× 400 0.9× 111 2.5k
Keshu Shan China 7 2.4k 1.0× 948 0.9× 609 0.9× 539 1.0× 287 0.7× 13 2.9k
Maaike C.G. Bleeker Netherlands 34 2.0k 0.8× 1.6k 1.5× 610 0.9× 640 1.2× 286 0.7× 103 3.2k
Markus Schmitt Germany 29 1.8k 0.7× 1.1k 1.1× 815 1.3× 610 1.1× 291 0.7× 64 3.0k
Anna Gillio‐Tos Italy 24 2.1k 0.9× 1.0k 1.0× 767 1.2× 578 1.1× 358 0.8× 51 2.8k
Anco Molijn Netherlands 30 2.6k 1.0× 1.1k 1.1× 1.1k 1.7× 522 1.0× 421 1.0× 57 3.4k
Svetlana Vinokurova Russia 24 1.7k 0.7× 621 0.6× 792 1.2× 524 1.0× 146 0.3× 54 2.2k
Ruediger Klaes Germany 14 1.5k 0.6× 615 0.6× 661 1.0× 567 1.1× 108 0.2× 24 2.0k

Countries citing papers authored by Linda Ho

Since Specialization
Citations

This map shows the geographic impact of Linda Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Ho more than expected).

Fields of papers citing papers by Linda Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Ho. The network helps show where Linda Ho may publish in the future.

Co-authorship network of co-authors of Linda Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Ho. A scholar is included among the top collaborators of Linda Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Ho. Linda Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartlett, Nancy L., Uwe Hahn, Won Seog Kim, et al.. (2025). Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 43(9). 1061–1072. 7 indexed citations
2.
Advani, Ranjana H., Alison J. Moskowitz, Nancy L. Bartlett, et al.. (2021). Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results. Blood. 138(6). 427–438. 116 indexed citations
3.
Cuzick, Jack, Linda Ho, George Terry, et al.. (2014). Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions. Journal of Clinical Virology. 60(1). 44–49. 45 indexed citations
4.
Terry, George, Linda Ho, P. Londesborough, et al.. (2006). The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. British Journal of Cancer. 96(1). 110–117. 16 indexed citations
5.
Terry, George, Linda Ho, P. Londesborough, et al.. (2004). The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. British Journal of Cancer. 91(12). 2056–2062. 6 indexed citations
6.
Ko, Chih‐Hung, et al.. (2004). Correlation of colposcopic anogenital findings and overall assessment of child sexual abuse: prospective study.. PubMed. 10(6). 378–83. 6 indexed citations
7.
Cuzick, Jack, Anne Szarewski, Heather Cubie, et al.. (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART study. The Lancet. 362(9399). 1871–1876. 389 indexed citations
8.
Terry, George, Linda Ho, P. Londesborough, & Jack Cuzick. (2002). Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions. British Journal of Cancer. 86(3). 376–381. 7 indexed citations
9.
Singer, Albert, et al.. (2002). Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples. American Journal of Obstetrics and Gynecology. 186(5). 962–968. 54 indexed citations
10.
Ho, Linda, et al.. (2000). The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). International Journal of Gynecological Cancer. 10(2). 143–150. 43 indexed citations
11.
Cuzick, Jack, Linda Ho, George Terry, et al.. (1999). HPV testing in primary screening of older women. British Journal of Cancer. 81(3). 554–558. 216 indexed citations
12.
Morris, Peter J., et al.. (1998). The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions.. Journal of Clinical Investigation. 101(8). 1687–1692. 33 indexed citations
13.
Terry, George, Linda Ho, & Jack Cuzick. (1997). Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. International Journal of Cancer. 73(5). 651–655. 36 indexed citations
14.
Londesborough, P., Linda Ho, George Terry, et al.. (1996). Human papillomavirus genotype as a predictor of persistence and development of high‐grade lesions in women with minor cervical abnormalities. International Journal of Cancer. 69(5). 364–368. 198 indexed citations
15.
Londesborough, P., Linda Ho, George Terry, et al.. (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. International Journal of Cancer. 69(5). 364–368. 192 indexed citations
16.
Odunsi, Kunle, George Terry, Linda Ho, et al.. (1995). Association Between HLA DQBl * 03 and Cervical Intra-epithelial Neoplasia. Molecular Medicine. 1(2). 161–171. 52 indexed citations
17.
Ho, Linda, et al.. (1994). Semi‐quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality. BJOG An International Journal of Obstetrics & Gynaecology. 101(9). 807–809. 21 indexed citations
18.
19.
Terry, George, et al.. (1993). Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique. Archives of Virology. 128(1-2). 123–133. 34 indexed citations
20.
Ho, Linda & Ami Cohen. (1975). Stability of simian virus 40 (SV40) mRNA species. Virology. 67(2). 588–590. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CJLM Meijer Breakdown of academic impact, for papers by Ruediger Ridder Breakdown of academic impact, for papers by Jesper Bonde Breakdown of academic impact, for papers by Keshu Shan Breakdown of academic impact, for papers by Maaike C.G. Bleeker Breakdown of academic impact, for papers by Markus Schmitt Breakdown of academic impact, for papers by Anna Gillio‐Tos Breakdown of academic impact, for papers by Anco Molijn Breakdown of academic impact, for papers by Svetlana Vinokurova Breakdown of academic impact, for papers by Ruediger Klaes
Rankless by CCL
2026